Intercept Pharmaceuticals, Inc.
ICPT · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3 | -$6 | -$32 | -$17 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $1 | -$2 | $0 | $0 |
| Stock-Based Comp. | $7 | $6 | $6 | $5 |
| Change in WC | $11 | -$22 | -$24 | $10 |
| Other Non-Cash | $1 | $1 | -$2 | -$3 |
| Operating Cash Flow | $17 | -$23 | -$52 | -$5 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | $0 | $0 |
| Net Acquisitions | -$60 | $0 | $0 | $55 |
| Inv. Purchases | -$35 | -$91 | -$56 | -$152 |
| Inv. Sales/Matur. | $95 | $188 | $121 | $96 |
| Other Inv. Act. | $60 | $0 | -$6 | -$55 |
| Investing Cash Flow | $60 | $97 | $59 | -$55 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$0 | -$0 | -$0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$110 | -$0 | -$0 | -$6 |
| Financing Cash Flow | -$110 | -$0 | -$0 | -$6 |
| Forex Effect | -$0 | $1 | -$0 | $1 |
| Net Chg. in Cash | -$34 | $74 | $7 | -$64 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $137 | $63 | $56 | $120 |
| End Cash | $104 | $137 | $63 | $56 |
| Free Cash Flow | $17 | -$23 | -$52 | -$5 |